Regulatory T cells: magic bullets for immunotherapy?

Arch Immunol Ther Exp (Warsz). 2006 Jan-Feb;54(1):33-43. doi: 10.1007/s00005-006-0008-0. Epub 2006 Feb 13.

Abstract

In the past few years it has been become increasingly clear that T cells capable of actively suppressing immune responses are thought to be in part responsible for the maintenance of peripheral self tolerance. In healthy rodents and humans, CD4(+) T cells constitutively expressing the interleukin (IL)-2 receptor alpha-chain (CD25) are able to exert such suppressive function in vitro and in vivo. Despite great efforts in our understanding of the biology of such immunoregulatory T cells, there are still certain points incompletely understood. Although some authors suggest that immunoregulatory cytokines such as IL-10 or transforming growth factor-beta are critical for the suppressive effect of these cells, this is controversial and the exact molecular nature and the targets of suppression are largely unknown. Thus far, until regulatory T cells can be used for diagnostic or therapeutic purposes many questions have to be answered. In this review we summarize the current knowledge on the function and properties of this T cell subset and discuss their potential role in human autoimmune or chronic inflammatory diseases.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / therapy
  • Cytokines / immunology
  • Humans
  • Immunotherapy*
  • Immunotherapy, Adoptive
  • Lymphocyte Activation
  • Neoplasms / immunology
  • Neoplasms / therapy
  • Receptors, Interleukin-2 / immunology
  • T-Lymphocytes, Regulatory / immunology*

Substances

  • Cytokines
  • Receptors, Interleukin-2